-
1
-
-
0027049068
-
Importance of beta 2-adrenergic receptors in heart failure
-
Brodde, O. E.; Daul, A.; Michel, M. C.; Zerkowski, H. R. Importance of beta 2-adrenergic receptors in heart failure. Z. Kardiol. 1992, 81 (Suppl. 4), 71-78.
-
(1992)
Z. Kardiol.
, vol.81
, Issue.4 SUPPL.
, pp. 71-78
-
-
Brodde, O.E.1
Daul, A.2
Michel, M.C.3
Zerkowski, H.R.4
-
2
-
-
0024337846
-
Myocardial beta-adrenoceptor changes in heart failure: Concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease
-
Brodde, O. E.; Zerkowski, H. R.; Doetsch, N.; Motomura, S.; Khamssi, M.; Michel, M. C. Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J. Am. Coll. Cardiol. 1989, 14, 323-331.
-
(1989)
J. Am. Coll. Cardiol.
, vol.14
, pp. 323-331
-
-
Brodde, O.E.1
Zerkowski, H.R.2
Doetsch, N.3
Motomura, S.4
Khamssi, M.5
Michel, M.C.6
-
3
-
-
0026689448
-
Chronic beta 1-blocker treatment and cardiac beta 2-adrenoceptor function
-
Brodde, O. E. Chronic beta 1-blocker treatment and cardiac beta 2-adrenoceptor function [letter]. Am. Heart J. 1992, 123, 1727-1728.
-
(1992)
Am. Heart J.
, vol.123
, pp. 1727-1728
-
-
Brodde, O.E.1
-
4
-
-
0024338393
-
Drug- and disease-induced changes of human cardiac beta-1 and beta-2 adrenoceptors
-
Brodde, O. E.; Zerkowski, H. R.; Borst, H. G.; Maier, W.; Michel, M. C. Drug- and disease-induced changes of human cardiac beta-1 and beta-2 adrenoceptors. Eur. Heart J. 1989, 10 (Suppl. B), 38-44.
-
(1989)
Eur. Heart J.
, vol.10
, Issue.SUPPL. B
, pp. 38-44
-
-
Brodde, O.E.1
Zerkowski, H.R.2
Borst, H.G.3
Maier, W.4
Michel, M.C.5
-
5
-
-
0022980843
-
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1- receptor down-regulation in heart failure
-
Bristow, M. R.; Ginsburg, R.; Umans, V.; Fowler, M.; Minobe, W.; Rasmussen, R.; Zera, P.; Menlove, R.; Shah, P.; Jamieson, S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1- receptor down-regulation in heart failure. Circ. Res. 1986, 59, 297-309.
-
(1986)
Circ. Res.
, vol.59
, pp. 297-309
-
-
Bristow, M.R.1
Ginsburg, R.2
Umans, V.3
Fowler, M.4
Minobe, W.5
Rasmussen, R.6
Zera, P.7
Menlove, R.8
Shah, P.9
Jamieson, S.10
-
6
-
-
0021856658
-
Beta-adrenergic function in heart muscle disease and heart failure
-
Bristow, M. R.; Kantrowitz, N. E.; Ginsburg, R.; Fowler, M. B. Beta-adrenergic function in heart muscle disease and heart failure. J. Mol. Cell Cardiol. 1985, 17 (Suppl. 2), 41-52.
-
(1985)
J. Mol. Cell Cardiol.
, vol.17
, Issue.2 SUPPL.
, pp. 41-52
-
-
Bristow, M.R.1
Kantrowitz, N.E.2
Ginsburg, R.3
Fowler, M.B.4
-
7
-
-
0025762367
-
Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method
-
Delforge, J.; Syrota, A.; Lancon, J. P.; Nakajima, K.; Loc'h, C.; Janier, M.; Vallois, J. M.; Cayla, J.; Crouzel, C. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J. Nucl. Med. 1991, 32, 739-748.
-
(1991)
J. Nucl. Med.
, vol.32
, pp. 739-748
-
-
Delforge, J.1
Syrota, A.2
Lancon, J.P.3
Nakajima, K.4
Loc'h, C.5
Janier, M.6
Vallois, J.M.7
Cayla, J.8
Crouzel, C.9
-
8
-
-
0027401947
-
Positron emission tomography with 11C CGP-12177 to assess beta- adrenergic receptor concentration in idiopathic dilated cardiomyopathy
-
Merlet, P.; Delforge, J.; Syrota, A.; Angevin, E.; Maziere, B.; Crouzel, C.; Valette, H.; Loisance, D.; Castaigne, A.; Rande, J. L. Positron emission tomography with 11C CGP-12177 to assess beta- adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993, 87, 1169-1178.
-
(1993)
Circulation
, vol.87
, pp. 1169-1178
-
-
Merlet, P.1
Delforge, J.2
Syrota, A.3
Angevin, E.4
Maziere, B.5
Crouzel, C.6
Valette, H.7
Loisance, D.8
Castaigne, A.9
Rande, J.L.10
-
9
-
-
0025877113
-
Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3′-t-butylamino-2′-hydroxypropoxy)- benzimidazol-2-[11C]one (S-[11C]CGP 12177) as a preferred radioligand for beta-adrenergic receptors
-
Brady, F.; Luthra, S. K.; Tochon Danguy, H. J.; Steel, C. J.; Waters, S. L.; Kensett, M. J.; Landais, P.; Shah, F.; Jaeggi, K. A.; Drake, A.; et al. Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3′-t-butylamino-2′-hydroxypropoxy)- benzimidazol-2-[11C]one (S-[11C]CGP 12177) as a preferred radioligand for beta-adrenergic receptors. Int. J. Radiat. Appl. Instrum. A 1991, 42, 621-628.
-
(1991)
Int. J. Radiat. Appl. Instrum. A
, vol.42
, pp. 621-628
-
-
Brady, F.1
Luthra, S.K.2
Tochon Danguy, H.J.3
Steel, C.J.4
Waters, S.L.5
Kensett, M.J.6
Landais, P.7
Shah, F.8
Jaeggi, K.A.9
Drake, A.10
-
10
-
-
0019196310
-
Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein
-
Cohen, M. L.; Ruffolo, R. R.; Wiley, K. S. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein. J. Pharmacol. Exp. Ther. 1980, 215, 325.
-
(1980)
J. Pharmacol. Exp. Ther.
, vol.215
, pp. 325
-
-
Cohen, M.L.1
Ruffolo, R.R.2
Wiley, K.S.3
-
11
-
-
0020501917
-
A comparison of the selectivity of carazolol with that of other beta-2 selective adrenoceptor antagonists
-
Costin, B. I.; O'Donnell, S. R.; Wanstall, J. C. A comparison of the selectivity of carazolol with that of other beta-2 selective adrenoceptor antagonists. J. Pharm. Pharmacol. 1983, 35, 590.
-
(1983)
J. Pharm. Pharmacol.
, vol.35
, pp. 590
-
-
Costin, B.I.1
O'Donnell, S.R.2
Wanstall, J.C.3
-
12
-
-
0018693255
-
Carazolol, an extremely potent β-adrenergic blocker: Binding to β-receptors in brain membranes
-
Innis, R. B.; Correa, F. M. A.; Snyder, S. H. Carazolol, an extremely potent β-adrenergic blocker: Binding to β-receptors in brain membranes. Life Sci. 1979, 24, 2255-2264.
-
(1979)
Life Sci.
, vol.24
, pp. 2255-2264
-
-
Innis, R.B.1
Correa, F.M.A.2
Snyder, S.H.3
-
13
-
-
0017853668
-
The affinity of carazolol for myocardial and tracheal β-adrenoceptors activated by (-)-isoprenaline
-
Lemoine, H.; Kaumann, A. J. The affinity of carazolol for myocardial and tracheal β-adrenoceptors activated by (-)-isoprenaline. Naunyn-Schmiedebergs Arch. Pharmacol. 1978, 302, R53.
-
(1978)
Naunyn-Schmiedebergs Arch. Pharmacol.
, vol.302
-
-
Lemoine, H.1
Kaumann, A.J.2
-
14
-
-
0022365171
-
Direct labelling of beta-2-adrenoceptors. A comparison of binding potency of 3H-ICI118,-551 and blocking potency of ICI118,551
-
Lemoine, H.; Ehle, B.; Kaumann, A. J. Direct labelling of beta-2-adrenoceptors. A comparison of binding potency of 3H-ICI118,-551 and blocking potency of ICI118,551. Naunyn-Schmiedebergs Arch. Pharmacol. 1985, 331, 40..
-
(1985)
Naunyn-Schmiedebergs Arch. Pharmacol.
, vol.331
, pp. 40
-
-
Lemoine, H.1
Ehle, B.2
Kaumann, A.J.3
-
15
-
-
0019395308
-
Characterization of [3H] (±) carazololbinding to β-adrenergic receptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung
-
Manalan, A. S.; Besch, H. R.; Watanabe, A. M. Characterization of [3H] (±) carazololbinding to β-adrenergic receptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung. Circ. Res. 1981, 49, 326.
-
(1981)
Circ. Res.
, vol.49
, pp. 326
-
-
Manalan, A.S.1
Besch, H.R.2
Watanabe, A.M.3
-
16
-
-
33544472678
-
Preparation and in vivo binding of [11C]carazolol, a radiotracer for the beta-adrenergic receptor
-
Berridge, M. S.; Cassidy, E. H.; Terris, A. H.; Vesselle, J. M. Preparation and in vivo binding of [11C]carazolol, a radiotracer for the beta-adrenergic receptor. Int. J. Radiat. Appl. Instrum. B 1992, 19, 563-569.
-
(1992)
Int. J. Radiat. Appl. Instrum. B
, vol.19
, pp. 563-569
-
-
Berridge, M.S.1
Cassidy, E.H.2
Terris, A.H.3
Vesselle, J.M.4
-
17
-
-
0029670104
-
(S,S)- and (S,R)-1′-[18F]fluorcarazolol, ligands for the visualization of pulmonary beta-adrenoceptors
-
Elsinga, P. H.; Vos, M. G.; Braker, A. H.; de Groot, T. J.; Van Waarde, A.; Anthonio, R. L.; Weemaes, A. M. A.; Brodde, O. E.; Visser, G. M.; Vaalburg, W. (S,S)- and (S,R)-1′-[18F]fluorcarazolol, ligands for the visualization of pulmonary beta-adrenoceptors. Nucl. Med. Biol. 1996, 23, 159-167.
-
(1996)
Nucl. Med. Biol.
, vol.23
, pp. 159-167
-
-
Elsinga, P.H.1
Vos, M.G.2
Braker, A.H.3
De Groot, T.J.4
Van Waarde, A.5
Anthonio, R.L.6
Weemaes, A.M.A.7
Brodde, O.E.8
Visser, G.M.9
Vaalburg, W.10
-
18
-
-
0028150716
-
Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist
-
Zheng, L.; Berridge, M. S.; Ernsberger, P. Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist. J. Med. Chem. 1994, 37, 3219-3230.
-
(1994)
J. Med. Chem.
, vol.37
, pp. 3219-3230
-
-
Zheng, L.1
Berridge, M.S.2
Ernsberger, P.3
-
19
-
-
0029990579
-
Pharmacological characterization in vitro and in vivo of 1231-labelled derivatives of the beta-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac beta-adrenoceptors
-
in press
-
Dubois, E. A.; Somsen, G. A.; van den Bos, J. C.; Janssen, A. G. M.; Boer, G. J.; Batink, H. D.; van Royen, E. A.; Pfaffendorf, M.; van Zwieten, P. A. Pharmacological characterization in vitro and in vivo of 1231-labelled derivatives of the beta-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac beta-adrenoceptors. J. Nucl. Cardiol. 1996, in press.
-
(1996)
J. Nucl. Cardiol.
-
-
Dubois, E.A.1
Somsen, G.A.2
Van Den Bos, J.C.3
Janssen, A.G.M.4
Boer, G.J.5
Batink, H.D.6
Van Royen, E.A.7
Pfaffendorf, M.8
Van Zwieten, P.A.9
-
20
-
-
0021258642
-
Different steric characteristics of beta 1- and beta 2-adrenoceptors
-
Morris, T. H.; Kaumann, A. J. Different steric characteristics of beta 1- and beta 2-adrenoceptors. Naunyn-Schmiedebergs Arch. Pharmacol. 1984, 327, 176-179.
-
(1984)
Naunyn-Schmiedebergs Arch. Pharmacol.
, vol.327
, pp. 176-179
-
-
Morris, T.H.1
Kaumann, A.J.2
-
21
-
-
0028107303
-
Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging
-
Shu, Y.; Scarpace, P. J. Forskolin binding sites and G-protein immunoreactivity in rat hearts during aging. J. Cardiovasc. Pharmacol. 1994, 23, 188-193.
-
(1994)
J. Cardiovasc. Pharmacol.
, vol.23
, pp. 188-193
-
-
Shu, Y.1
Scarpace, P.J.2
-
22
-
-
0000209289
-
Arenesulfonate derivatives of homochiral glycidol: Versatile chiral building-blocks for organic synthesis
-
Klunder, J. M.; Onami, T.; Sharpless, K. B. Arenesulfonate derivatives of homochiral glycidol: versatile chiral building-blocks for organic synthesis. J. Org. Chem. 1989, 54, 1295-1304.
-
(1989)
J. Org. Chem.
, vol.54
, pp. 1295-1304
-
-
Klunder, J.M.1
Onami, T.2
Sharpless, K.B.3
-
23
-
-
10144226195
-
Verfahren zur Herstellung von 4-hydroxycarbazol
-
Ger. Offen DE 2928483, Boehringer Mannheim GmbH, Germany
-
Lauer, K.; Kiegel, E. Verfahren zur Herstellung von 4-hydroxycarbazol. (A method for the synthesis of 4-hydroxycarbazole.) Ger. Offen DE 2928483, Boehringer Mannheim GmbH, Germany; Chem. Abstr. 1981, 93, 114325.
-
(1981)
Chem. Abstr.
, vol.93
, pp. 114325
-
-
Lauer, K.1
Kiegel, E.2
-
24
-
-
10144256296
-
Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole
-
U.S. Patent No. 3892766, Warner-Lamberts Co.
-
Zinnes, H. Process for the preparation of 4-keto-1,2,3,4-tetrahydrocarbazole. U.S. Patent No. 3892766, Warner-Lamberts Co.; Chem. Abstr. 1975, 83, 178814v.
-
(1975)
Chem. Abstr.
, vol.83
-
-
Zinnes, H.1
-
25
-
-
0026513574
-
S-[1-(2,3-Diaminophenoxy)]-3′-(N-t-butylamino)propan-2′-ol. Simplified asymmetric synthesis with CD and chiral HPLC analysis
-
Aigbirhio, F.; Pike, V. W.; Francotte, E.; Waters, S. L.; Banfield, B.; Jaeggi, K. A.; Drake, A. S-[1-(2,3-Diaminophenoxy)]-3′-(N-t-butylamino)propan-2′-ol. Simplified asymmetric synthesis with CD and chiral HPLC analysis. Tetrahedron: Asymmetry 1992, 3, 539-554.
-
(1992)
Tetrahedron: Asymmetry
, vol.3
, pp. 539-554
-
-
Aigbirhio, F.1
Pike, V.W.2
Francotte, E.3
Waters, S.L.4
Banfield, B.5
Jaeggi, K.A.6
Drake, A.7
-
26
-
-
37049069856
-
Synthesis of 4-N,N-dimethyl(aminoethyl)-1,2,3,4-tetrahydrocarbazole: Molecular structure and reactivity of the 1,2-dihydrocarbazol-4(3H)-one and derivatives
-
Rodriguez, J.-G.; Temprano, F.; Esteban-Calderon, C.; Martinez-Ripoll, M. Synthesis of 4-(N,N-dimethyl(aminoethyl)-1,2,3,4-tetrahydrocarbazole: molecular structure and reactivity of the 1,2-dihydrocarbazol-4(3H)-one and derivatives. J. Chem. Soc., Perkin Trans. I 1989, 2117-2122.
-
(1989)
J. Chem. Soc., Perkin Trans. I
, pp. 2117-2122
-
-
Rodriguez, J.-G.1
Temprano, F.2
Esteban-Calderon, C.3
Martinez-Ripoll, M.4
-
27
-
-
0019732048
-
(+/-)[125Iodo] cyanopindolol, a new ligand for beta- adrenoceptors: Identification and quantitation of subclasses of beta-adrenoceptors in guinea pig
-
Engel, G.; Hoyer, D.; Berthold, R.; Wagner, H. (+/-)[125Iodo] cyanopindolol, a new ligand for beta- adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. Naunyn-Schmiedebergs. Arch. Pharmacol. 1981, 317, 277-285.
-
(1981)
Naunyn-Schmiedebergs. Arch. Pharmacol.
, vol.317
, pp. 277-285
-
-
Engel, G.1
Hoyer, D.2
Berthold, R.3
Wagner, H.4
-
28
-
-
0026825699
-
Vinylstannylated alkylating agents as prosthetic groups for radioiodination of small molecules; Design, synthesis and application to iodoallyl analogues of spiperone and diprenorphine
-
Musachio, J. L.; Lever, J. R. Vinylstannylated alkylating agents as prosthetic groups for radioiodination of small molecules; Design, synthesis and application to iodoallyl analogues of spiperone and diprenorphine. Bioconjugate Chem. 1992, 3, 167-175.
-
(1992)
Bioconjugate Chem.
, vol.3
, pp. 167-175
-
-
Musachio, J.L.1
Lever, J.R.2
|